Physician profile
Sameea Husain
NPI 1518160852
$32,889.07
in general payments reported to CMS, 2019-2025
37 companies · $5,493 in 2025
The $5,493 reported for 2025 was more than what 86% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,658 · 2020: $6,509 · 2021: $5,503 · 2022: $3,288 · 2023: $1,497 · 2024: $3,940 · 2025: $5,493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $6,802 · Food and Beverage: $3,342 · Education: $786.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $6,802.00 |
| Food and Beverage | $3,342.38 |
| Education | $785.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $19,174.41 | 2019-2025 | Crexont, Rytary, Ongentys 50mg Capsules 30 |
| Abbvie INC. | $7,226.29 | 2019-2025 | |
| Acorda Therapeutics, INC | $2,383.85 | 2019-2024 | Inbrija |
| Pfizer INC. | $618.02 | 2023-2025 | |
| Acadia Pharmaceuticals INC | $350.82 | 2019-2025 | Nuplazid |
| Medtronic, INC. | $307.89 | 2024-2025 | Linq II, Percept Pc Brainsense, Activa Pc |
| Ucb, INC. | $294.99 | 2019-2024 | Briviact |
| Mdd US Operations, LLC | $288.85 | 2019-2023 | Apokyn |
| Emd Serono, INC. | $238.77 | 2019-2024 | |
| Genentech USA, INC. | $211.78 | 2019-2023 | Ocrevus, Evrysdi |
| Neurocrine Biosciences, INC. | $208.00 | 2024-2025 | Ingrezza |
| Abbott Laboratories | $178.18 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $166.07 | 2019-2025 | Austedo Xr |
| Amgen INC. | $155.64 | 2019-2021 | |
| Allergan, INC. | $130.24 | 2019-2021 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameea Husain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.